ABEO Abeona Therapeutics Inc.
$5.42▼ -1.19%
Healthcare
Other
After hours
$5.47▲ +0.98%
Sep 11, 7:30 PM ET
Volume 1.55M
Avg Volume (10D) 1.09M
Key Metrics & Fundamentals
Market Cap
$309.65M
P/E Ratio
6.7
Div Yield
–%
52W Range
4.00 - 7.65
% vs 50 MA
-15.45%
% vs 200 MA
-1.92%
RSI-14
32.4
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$17.98M
Gross Rev
$11.38M
Gross Profit
$7.20M
EBITDA
-$11.47M
COGS
$4.18M
Operating Exp
$20.86M
Operating Income
-$13.65M
EBIT
-$13.65M
Pretax Income
-$20.19M
Net Income
-$20.19M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 11:30 AM

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 1, 2026 11:30 AM

Abeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone
Insider Monkey · Aug 21, 2026 3:42 PM
Abeona Therapeutics Inc (ABEO) (Q2 2026) Earnings Call Highlights: ZEVASKYN Revenue Surges 31% ...
GuruFocus.com · Aug 17, 2026 7:03 PM
ABEO: Zevaskyn® Launch Gains Momentum
Zacks Small Cap Research · Aug 17, 2026 3:05 PM
Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating
MT Newswires · Aug 14, 2026 12:43 PM

Abeona Therapeutics Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 8:56 PM
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Aug 13, 2026 7:36 PM
Sector Update: Healthcare
MT Newswires · Aug 13, 2026 7:07 PM
Abeona Therapeutics Shares Fall After Q2 Miss
MT Newswires · Aug 13, 2026 6:49 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ABEO's money flow as a full page
Social Sentiment
No Reddit posts found for ABEO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.